PDE7A1 hydrolyzes cCMP

FEBS Letters

Volumn 588, Issue 18, 2014, Pages 3469-3474

  Monzel, Maike ^a   Kuhn, Maike ^a   Bähre, Heike ^a   Seifert, Roland ^a   Schneider, Erich H ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

Author keywords

Cyclic CMP; Cyclic nucleotides; Enzyme kinetics; HPLCMS; Phosphodiesterase; Second messenger

Indexed keywords

CYCLIC AMP; CYCLIC CMP; GLUTATHIONE; NUCLEOSIDE 3',5' CYCLIC MONOPHOSPHATE; NUCLEOTIDE DERIVATIVE; PHOSPHODIESTERASE; PHOSPHODIESTERASE 7A; PHOSPHODIESTERASE 7A1; PURINE NUCLEOTIDE; RECOMBINANT ENZYME; UNCLASSIFIED DRUG; 3 (N,N DIMETHYLSULFONAMIDO) 4 METHYL NITROBENZENE; 3-(N,N-DIMETHYLSULFONAMIDO)-4-METHYL-NITROBENZENE; NITRO DERIVATIVE; PDE7A PROTEIN, HUMAN; PHOSPHODIESTERASE INHIBITOR; PHOSPHODIESTERASE VII; SULFONAMIDE;

ANIMAL CELL; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DEGRADATION; ENZYME KINETICS; ENZYME SPECIFICITY; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; HYDROLYSIS; INTRINSIC CLEARANCE; NONHUMAN; PRIORITY JOURNAL; TANDEM MASS SPECTROMETRY; VELOCITY; ANIMAL; CHEMISTRY; CYCLIC NUCLEOTIDES; DRUG ANTAGONISM; HPLC-MS; HUMAN; KINETICS; SECOND MESSENGER; SF9 CELL LINE; SPODOPTERA; TUMOR CELL LINE;

CYCLIC CMP; CYCLIC NUCLEOTIDES; ENZYME KINETICS; HPLC-MS; PHOSPHODIESTERASE; SECOND MESSENGER;

ANIMALS; CELL LINE, TUMOR; CYCLIC AMP; CYCLIC CMP; CYCLIC NUCLEOTIDE PHOSPHODIESTERASES, TYPE 7; HUMANS; HYDROLYSIS; KINETICS; NITRO COMPOUNDS; PHOSPHODIESTERASE INHIBITORS; SECOND MESSENGER SYSTEMS; SF9 CELLS; SPODOPTERA; SUBSTRATE SPECIFICITY; SULFONAMIDES;

EID: 84908701308     PISSN: 00145793     EISSN: 18733468     Source Type: Journal    
DOI: 10.1016/j.febslet.2014.08.005     Document Type: Article

References (29)

1. S.Y. Cech, and L.J. Ignarro Cytidine 3′,5′-monophosphate (cyclic CMP) formation in mammalian tissues Science 198 1977 1063 1065
2. R.M. Gaion, and G. Krishna Cytidylate cyclase: the product isolated by the method of Cech and Ignarro is not cytidine 3′,5′-monophosphate Biochem. Biophys. Res. Commun. 86 1979 105 111
3. 1 Biochemistry 51 2012 194 204
4. A. Hasan, K.Y. Danker, S. Wolter, H. Bähre, V. Kaever, and R. Seifert Soluble adenylyl cyclase accounts for high basal cCMP and cUMP concentrations in HEK293 and B103 cells Biochem. Biophys. Res. Commun. 448 2014 236 240
5. D. Reinecke, H. Burhenne, P. Sandner, V. Kaever, and R. Seifert Human cyclic nucleotide phosphodiesterases possess a much broader substrate-specificity than previously appreciated FEBS Lett. 585 2011 3259 3262
6. 1 Biol. Chem. 394 2013 261 270
7. U. Beckert, S. Wolter, C. Hartwig, H. Bähre, V. Kaever, D. Ladant, D.W. Frank, and R. Seifert ExoY from Pseudomonas aeruginosa is a nucleotidyl cyclase with preference for cGMP and cUMP formation Biochem. Biophys. Res. Commun. 450 2014 870 874
8. Hartwig, C., Bähre, H., Wolter, S., Beckert, U., Kaever, V., Seifert, R. (2014) cAMP, cGMP, cCMP and cUMP concentrations across the tree of life: high cCMP and cUMP levels in astrocytes. Neurosci. Lett. (in press). http://dx.doi/org/10.1016/j.neulet.2014.07.019.
9. X. Zong, S. Krause, C.C. Chen, J. Krüger, C. Gruner, X. Cao-Ehlker, S. Fenske, C. Wahl-Schott, and M. Biel Regulation of hyperpolarization-activated cyclic nucleotide-gated (HCN) channel activity by cCMP J. Biol. Chem. 287 2012 26506 26512
10. A. Hammerschmidt, B. Chatterji, J. Zeiser, A. Schröder, H.G. Genieser, A. Pich, V. Kaever, F. Schwede, S. Wolter, and R. Seifert Binding of regulatory subunits of cyclic AMP-dependent protein kinase to cyclic CMP agarose PLoS One 7 2012 e39848
11. S. Wolter, M. Golombek, and R. Seifert Differential activation of cAMP- and cGMP-dependent protein kinases by cyclic purine and pyrimidine nucleotides Biochem. Biophys. Res. Commun. 415 2011 563 566
12. M. Desch, E. Schinner, F. Kees, F. Hofmann, R. Seifert, and J. Schlossmann Cyclic cytidine 3′,5′-monophosphate (cCMP) signals via cGMP kinase I FEBS Lett. 584 2010 3979 3984
13. Y.C. Cheng, and A. Bloch Demonstration, in leukemia L-1210 cells, of a phosphodiesterase acting on 3′:5′-cyclic CMP but not on 3′:5′-cyclic AMP or 3′:5′-cyclic GMP J. Biol. Chem. 253 1978 2522 2524
14. R.P. Newton, and S.G. Salih Cyclic CMP phosphodiesterase: isolation, specificity and kinetic properties Int. J. Biochem. 18 1986 743 752
15. J.F. Kuo, N.L. Brackett, M. Shoji, and J. Tse Cytidine 3′:5′-monophosphate phosphodiesterase in mammalian tissues. Occurrence and biological involvement J. Biol. Chem. 253 1978 2518 2521
16. R.P. Newton, M.A. Bayliss, J.A. Khan, A. Bastani, A.C. Wilkins, D.E. Games, T.J. Walton, A.G. Brenton, and F.M. Harris Kinetic analysis of cyclic CMP-specific and multifunctional phosphodiesterases by quantitative positive-ion fast-atom bombardment mass spectrometry Rapid Commun. Mass Spectrom. 13 1999 574 584
17. D.M. Helfman, M. Shoji, and J.F. Kuo Purification to homogeneity and general properties of a novel phosphodiesterase hydrolyzing cyclic CMP and cyclic AMP J. Biol. Chem. 256 1981 6327 6334
18. B.E. Lavan, T. Lakey, and M.D. Houslay Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form Biochem. Pharmacol. 38 1989 4123 4136
19. A. Worby, L.M. Mensah, and K.J. Murray Identification of the novel rat liver IBMX-insensitive phosphodiesterase as a non-specific phosphodiesterase capable of hydrolysing cCMP Biochem. Pharmacol. 42 1991 1318 1321
20. D.B. Mendel, T. Cihlar, K. Moon, and M.S. Chen Conversion of 1-[((S)-2-hydroxy-2-oxo-1,4,2-dioxaphosphorinan-5-yl)methyl]cytosine to cidofovir by an intracellular cyclic CMP phosphodiesterase Antimicrob. Agents Chemother. 41 1997 641 646
21. D.M. Helfman, and J.F. Kuo A homogeneous cyclic CMP phosphodiesterase hydrolyzes both pyrimidine and purine cyclic 2′:3′- and 3′:5′-nucleotides J. Biol. Chem. 257 1982 1044 1047
22. A.T. Bender, and J.A. Beavo Cyclic nucleotide phosphodiesterases: molecular regulation to clinical use Pharmacol. Rev. 58 2006 488 520
23. S.J. Smith, L.B. Cieslinski, R. Newton, L.E. Donnelly, P.S. Fenwick, A.G. Nicholson, P.J. Barnes, M.S. Barnette, and M.A. Giembycz Discovery of BRL 50481 [3-(N,N-dimethylsulfonamido)-4-methyl-nitrobenzene], a selective inhibitor of phosphodiesterase 7: in vitro studies in human monocytes, lung macrophages, and CD8+ T-lymphocytes Mol. Pharmacol. 66 2004 1679 1689
24. M. Vecsler, I. Lazar, and A. Tzur Using standard optical flow cytometry for synchronizing proliferating cells in the G1 phase PLoS One 8 2013 e83935
25. M. Göttle, S. Dove, F. Kees, J. Schlossmann, J. Geduhn, B. König, Y. Shen, W.J. Tang, V. Kaever, and R. Seifert Cytidylyl and uridylyl cyclase activity of bacillus anthracis edema factor and Bordetella pertussis CyaA Biochemistry 49 2010 5494 5503
26. K.Y. Beste, C.M. Spangler, H. Burhenne, K.W. Koch, Y. Shen, W.J. Tang, V. Kaever, and R. Seifert Nucleotidyl cyclase activity of particulate guanylyl cyclase A: comparison with particulate guanylyl cyclases E and F, soluble guanylyl cyclase and bacterial adenylyl cyclases CyaA and edema factor PLoS One 8 2013 e70223
27. T.C. Stevens, C.D. Ochoa, K.A. Morrow, M.J. Robson, N. Prasain, C. Zhou, D.F. Alvarez, D.W. Frank, R. Balczon, and T. Stevens The Pseudomonas aeruginosa exoenzyme Y impairs endothelial cell proliferation and vascular repair following lung injury Am. J. Physiol. Lung Cell. Mol. Physiol. 306 2014 L915 24
28. S. Laue, M. Winterhoff, V. Kaever, J.J. van den Heuvel, F.G. Russel, and R. Seifert cCMP is a substrate for MRP5 Naunyn Schmiedebergs Arch. Pharmacol. 387 2014 893 895
29. P. Han, X. Zhu, and T. Michaeli Alternative splicing of the high affinity cAMP-specific phosphodiesterase (PDE7A) mRNA in human skeletal muscle and heart J. Biol. Chem. 272 1997 16152 16157